Social Determinants of Health in Metabolic Dysfunction‐Associated Steatotic Liver Disease and All‐Cause/Cause‐Specific Mortality
Alimentary Pharmacology & Therapeutics · 2026
DOI: 10.1111/apt.70409 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2026. Verfasst von Donghee Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California, USA. Hauptthemen laut MEDLINE: Social Determinants of Health, Fatty Liver, Metabolic Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: NCATS NIH HHS, NIDDK NIH HHS, NIAAA NIH HHS.
Abstract (Originalsprache)
Background
Social determinants of health (SDoH) are the preventable health inequities, and the associations between SDoH and health outcomes among individuals with metabolic dysfunction‐associated steatotic liver disease (MASLD) remain unclear.
Aims
We investigated the relationship between SDoH and mortality in individuals with MASLD in the US.
Methods
We conducted a retrospective analysis using data from the 2007–2016 National Health and Nutrition Examination Survey, with follow‐up mortality data assessed through 2019. SDoH score was derived from questionnaires, and MASLD was defined using non‐invasive panels and cardiometabolic criteria. Cox regression models were used to evaluate the association between SDoH and all‐cause/cause‐specific mortality among individuals with MASLD.
Results
We analysed 12,321 individuals with MASLD (mean age: 47.0 years; 48.4% males). Over a median follow‐up period of 7.6 years, higher SDoH scores were associated with progressively increased hazards of all‐cause mortality. The results remained consistent in a multivariable model. Additionally, higher unfavourable SDoH scores were associated with increased cardiovascular and cancer‐related mortality. Specifically, there was a 32% increase in hazards for all‐cause mortality (hazard ratio [HR]: 1.32, 95% confidence interval [CI]: 1.25–1.38) and increases of 29% and 21% for cardiovascular (HR: 1.29, 95% CI: 1.19–1.40) and cancer‐related mortality (HR: 1.21, 95% CI: 1.07–1.36), respectively, for each one‐point increase in SDoH score. Employment status, food insecurity, family income, private insurance coverage, and marital status were independently associated with all‐cause mortality in individuals with MASLD.
Conclusions
This US population‐based study demonstrates that SDoH scores are dose‐dependently associated with increased all‐cause/cause‐specific mortality among individuals with MASLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California, USA.
- Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
- Division of Gastroenterology and Hepatology, Department of Medicine, University of Arizona College of Medicine, Phoenix, Arizona, USA.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Banner University Medical Center, Phoenix, Arizona, USA.
- Division of Gastroenterology and Epidemiology, University of California at San Diego, La Jolla, California, USA.
ORCID-Profile: Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, Rohit Loomba, Aijaz Ahmed
Förderung
- NCATS NIH HHS
- NIDDK NIH HHS
- NIAAA NIH HHS
- John C Martin Foundation
- NHLBI NIH HHS
- National Institute on Alcohol Abuse and Alcoholism
- National Heart, Lung, and Blood Institute
- National Center for Advancing Translational Sciences
Zitieren
APA
Kim, D., Danpanichkul, P., Wijarnpreecha, K., Loomba, R., & Ahmed, A. (2026). Social Determinants of Health in Metabolic Dysfunction‐Associated Steatotic Liver Disease and All‐Cause/Cause‐Specific Mortality. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70409
Vancouver
Kim D, Danpanichkul P, Wijarnpreecha K, Loomba R, Ahmed A. Social Determinants of Health in Metabolic Dysfunction‐Associated Steatotic Liver Disease and All‐Cause/Cause‐Specific Mortality. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.70409
BibTeX
@article{Kim2026,
author = {Kim, Donghee and Danpanichkul, Pojsakorn and Wijarnpreecha, Karn and Loomba, Rohit and Ahmed, Aijaz},
title = {Social Determinants of Health in Metabolic Dysfunction‐Associated Steatotic Liver Disease and All‐Cause/Cause‐Specific Mortality},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
doi = {10.1111/apt.70409}
}
EUVIMED